Dose of alendronate directly increases trabeculae expansivity without altering bone volume in rat femurs.

AIM: To evaluate the effects of sodium alendronate on bone repair in fractures created in appendicular bones.

METHODS: Wistar rats ( n = 36) were allocated into three distinct groups: group C (control), group B1 (received 1 mg/kg of alendronate), and group B2 (received 3 mg/kg of alendronate). The rats underwent femoral transversal linear fracture surgery using stable internal fixation with a 2.0 mm plate and screw system. Each animal randomly received intraperitoneal applications of sodium alendronate at a dose corresponding to group B1 or B2 three times a week, while the control group received a 0.9% saline solution. Drug administration was performed until euthanasia at 45 d. The femurs were removed and each surgical piece was sent for radiographic, tomographic and microtomographic analysis. Data were submitted to descriptive and inferential statistical analysis (95% confidence interval).

RESULTS: Quantitative evaluations of bone neoformation did not show differences among the groups in the radiographic ( P = 0.341), microtomographic ( P = 0.581) and tomographic evaluations ( P = 0.171). In the qualitative microtomographic analysis, a smaller distance was observed between the internal bone trabeculae in the groups that used alendronate ( P = 0.05). On the other hand, group B2 had a higher amount of bone trabeculae per unit length when compared to the other groups ( P = 0.04).

CONCLUSION: It is likely that the use of alendronate did not have a direct influence on the amount of bone neoformation, however it did influence the bone quality in a dose-dependent manner, ultimately affecting the distance and quantity of the trabeculae.